At the Business Standard BFSI Insight Summit 2025, Non-Executive Chairman of Jio Financial Services KV Kamath said country's financial ecosystem has evolved to give consumers greater choice
With mega IPOs from Lenskart and Groww ahead, India's record ₹1.6 trillion fundraising looks set to be topped, says Ramchandani
SBI Chairman CS Setty said India needs deeper capital markets, innovation, and financial talent to achieve the Viksit Bharat 2047 vision, speaking at the Stockbrokers' Business Meet
Separately, the regulator is weighing the introduction of a variable pay component of up to 25 per cent for certain key managerial employees of MIIs in their annual remuneration
MCX share price rallied 5.6% on the NSE to hit an intraday high of ₹7,805 per share. Those of Anand Rathi Wealth, meanwhile, climbed 5.2% , and BSE share price 4.8% today
The Nifty Capital Markets index, top loser among NSE indices, was down 1.52 per cent, as compared to a 0.22 per cent rise in the Nifty 50
With enough firepower to counter FIIs, DIIs have made India's equity market more resilient, but what's driving the shift?
Kinara Capital defaults on payments and proposes a calm period via an intercreditor pact as it seeks to preserve cash and resume repayments from October 2025
Capital markets regulator Sebi on Tuesday levied a fine of Rs 10 lakh on an entity for trading in the shares of HDFC Ltd and HDFC Bank while in possession of unpublished price sensitive information (UPSI) related to their merger. Sebi found that Rupesh Satish Dalal HUF had traded in derivatives of both HDFC entities on April 1, 2022 -- just days before the official announcement of the merger between HDFC Ltd and HDFC Bank on April 4, 2022. Rupesh Satish Dalal is the karta of Rupesh Satish Dalal HUF. The regulator's probe revealed that Dalal had received UPSI through his son, who was in close and regular contact with a person (individual) who was an insider associated with Deloitte. Deloitte Touche Tohmatsu India LLP was engaged as the valuer for the merger exercise and the individual was part of the valuation team from March 29, 2022. The individual and Dalal's son were long-time friends and exchanged several calls in the run-up to the trades. Sebi also noted that a meeting betwee
Nuvama and UTI AMC are top stocks in the capital markets sector for Motilal Oswal, as the medium-term outlook for the sector is constructive
ECM activity has rebounded sharply over the last couple of months, with significant pickup in IPOs and block deals, says Davda
Rs 1,398.6 crore all-cash acquisition will boost UGRO's MSME lending scale, add school finance, and improve profitability and secured asset mix
Of the 270 companies analysed, largecaps saw a 6 per cent Y-o-Y earnings rise, midcaps gained 2 per cent, while smallcaps slumped 16 per cent.
Indian firms including Vedanta, Jubilant and HUDCO raised over Rs 12,000 crore from bonds ahead of the RBI's expected 25 bps repo rate cut, with strong demand from mutual funds
Paritosh Kashyap, Group president and business head, Wholesale Banking Group, will be appointed as the whole-time director (executive director) and key managerial personnel
The regulator is looking into possible violations of listing obligation and disclosure requirements regulations
Lower hedging cost, demand for high-yield paper, need to diversify borrowing sources drove the fund raise
DIC India has settled a case with capital markets regulator Sebi pertaining to alleged violation of disclosure lapses after paying Rs 34.32 lakh towards the settlement amount. DIC India, a manufacturer of printing inks and allied products, had filed suo motu settlement applications in terms of the Sebi's (Settlement Proceedings) regulations, the regulator said in an order on March 21. The company proposed to settle by neither "admitting nor denying the findings of fact and conclusions of law" the enforcement proceedings that may be initiated against it for the violation of rules. As per the settlement order, the markets watchdog will not initiate enforcement proceedings against DIC India for the violations. However, Sebi retains the right to take further action if any misrepresentation is discovered or if the company breaches any terms of the settlement. "...it is hereby ordered that any proceedings that may be initiated for the violations are settled in respect of the applicant
Capital markets regulator Sebi on Tuesday slapped penalties totalling Rs 20 lakh on four entities for indulging in non-genuine trades in the illiquid stock options segment on the BSE. In four separate orders, the regulator imposed a fine of Rs 5 lakh each on Nirman Chatha, Rajvardhan Foundation, Dinesh Kumar Agarwal HUF and Pramod Kumar Jain. The orders came after the Securities and Exchange Board of India (Sebi) observed large-scale reversal of trades in the illiquid stock options segment of BSE, leading to the creation of artificial volume. Thereafter, the markets watchdog conducted an investigation into the trading activities of certain entities in illiquid stock options at BSE for the period April 2014 to September 2015. According to Sebi, reversal trades are those trades in which an entity reverses its buy or sell positions in a contract with a subsequent sell or buy position with the same counterparty. These trades are alleged to be non-genuine trades as they lack basic trad
Capital markets regulator Sebi's recent directive on minimum information has many inconsistencies and is "laughable", former Sebi chairman M Damodaran said on Wednesday. Addressing an event organized by the Institute of Internal Auditors here, Damodaran said we will not be able to see good governance at companies if there are prescriptive arrangements, and advocated that such practices come from within. He quipped that the February 14 directive on industry standards on minimum information to be provided for review by the audit committee and shareholders for approval of a related party transaction is a "very elaborate" document. "Even the tabular statement is several pages long. It has so many things that if you take them seriously, you will have a problem. So it's better to read them, laugh at them and go on with life," the IAS officer-turned-regulator said. "There are inconsistencies within that document. There are inconsistencies that that document has with other prescriptions fr